Latest 10-K annual reports

Myers Industries reports a significant increase in net income and improved gross profit margin in 2025, driven by strategic acquisitions and cost management, despite a slight revenue dip and ongoing divestiture plans.

Tango Therapeutics, Inc. filed its annual 10-K report, highlighting positive clinical data for vopimetostat and TNG260, strategic collaborations, and a cash runway into 2028.

CPI Card Group reports increased revenue driven by the Arroweye acquisition and contactless card demand, despite a dip in net income and gross profit margin, while strategically expanding digital solutions and refining its segment structure.

Liquidia Corporation achieved its first product sales of YUTREPIA in 2025, generating $148.3 million, but faces significant ongoing litigation and continued net losses.

Shattuck Labs, a clinical-stage biotech, is advancing its lead DR3 blocking antibody, SL-325, into Phase 2 for Crohn's Disease while reporting a reduced net loss for fiscal year 2025.

Palladyne AI Corp. reported a net income of $10.0 million for 2025, a significant improvement from the prior year's loss, driven by non-cash gains and strategic acquisitions despite a decline in revenue and increased operational losses.

Latham Group, Inc. reported a significant turnaround in 2025, achieving net income of $11.1 million on increased net sales, driven by strong fiberglass pool and automatic safety cover adoption.

Roman DBDR Acquisition Corp. II filed its annual 10-K report, outlining its proposed business combination with ThomasLloyd Climate Solutions B.V. and reporting a material weakness in internal controls.

Safeguard Acquisition Corp.'s 10-K details its SPAC structure, search for a business combination in defense and space, and outlines significant risks for investors.

MicroVision reported a significant revenue decline and substantial net losses for 2025, alongside strategic acquisitions and ongoing capital raises, while facing a Nasdaq minimum bid price compliance issue.

Everspin Technologies, a leader in MRAM technology, reported a 9.5% increase in total revenue to $55.2 million for 2025, alongside a net loss of $0.6 million, driven by strong product sales and increased R&D.

Seaport Entertainment Group Inc. reported a significant reduction in net losses and an 18% revenue increase for fiscal year 2025, driven by hospitality and entertainment growth, despite ongoing negative operating cash flow.

SES AI Corporation's 2025 annual report highlights significant revenue growth driven by ESS sales and service contracts, alongside strategic shifts towards AI-enhanced battery technology and joint venture manufacturing.

BioLargo, Inc. reported a significant increase in net loss and a 56% revenue decrease for fiscal year 2025, primarily driven by a credit loss from a key customer and ongoing litigation.

Middleby Corporation reports a net loss in fiscal 2025 driven by a residential kitchen equipment divestiture and plans a Food Processing spin-off, while facing sales declines in continuing operations.

Riley Exploration Permian, Inc. reports increased proved reserves and production for 2025, driven by strategic acquisitions and development, despite volatile commodity prices.

Ring Energy, Inc. reported a net loss of $34.7 million for 2025, driven by lower commodity prices and a significant ceiling test impairment, despite achieving record full-year production.

OrthoPediatrics Corp. announced a 15% revenue increase to $236.3 million in 2025, driven by core product performance and strategic acquisitions, despite continued operating losses.

Viemed Healthcare reported 20.5% revenue growth and a 34.8% rise in net income for 2025, expanded via acquisitions, resupply programs, and home respiratory care, while authorizing a new 2026 share buyback.

Red Violet, Inc. announced robust financial results for fiscal year 2025, driven by significant revenue and net income growth, alongside expansion of its customer and user bases.

NACCO Industries, Inc. reported increased revenues but a significant drop in net income for 2025, driven by a non-cash pension charge and absence of prior year insurance recoveries, while outlining strategic growth in contract mining and natural resources.

OmniAb, Inc. reported a 29% decrease in total revenue and an increased net loss for fiscal year 2025, despite growth in active partnerships and the launch of new antibody discovery technologies.

TriplePoint Venture Growth BDC Corp. reports a net increase in net assets of $49.2 million for 2025, driven by investment income and realized gains, alongside strategic debt management and an incentive fee waiver.

Third Coast Bancshares, Inc. reported significant financial growth in 2025, including a 39.1% increase in net income, and successfully completed its merger with Keystone Bancshares, Inc. in early 2026.

Global Water Resources, Inc. reported a 5.8% revenue increase in 2025, driven by organic growth and acquisitions, but saw net income decline by 48.9% due to higher operating expenses and non-recurring losses.

Nine Energy Service, Inc. has filed for Chapter 11 bankruptcy, leading to the cancellation of existing common stock and a financial restructuring.

Mayville Engineering Company, Inc. (MEC) reported a net loss of $8.1 million for fiscal year 2025, a significant decline from the prior year, driven by reduced customer demand and acquisition-related costs, despite strategic expansion into the data center market.

European Wax Center, Inc. reported a decline in key financial metrics for fiscal year 2025, alongside a proposed merger agreement with its largest stockholder, General Atlantic, offering $5.80 per Class A common stock.

Octave Specialty Group, formerly Ambac Financial Group, completed its pivot to specialty property & casualty and insurance distribution, reporting a higher net loss from continuing operations in 2025 despite revenue growth driven by acquisitions.

Cardlytics reports improved Adjusted EBITDA and positive operating cash flow for 2025, despite revenue and billings decline, as Bridg is sold.